Category Archives: Anatomy

Late-breaking abstract one of nine abstracts selected by SITC Communications Committee to be showcased at the SITC 2022 Press Conference

See the original post:
Immutep Announces Abstract Highlighting Eftilagimod Alpha Selected for SITC 2022 Annual Meeting Press Conference

Six-month outcomes are expected in second quarter of 2023 Six-month outcomes are expected in second quarter of 2023

Read the original here:
Osteal Therapeutics, Inc. Completes Enrollment in APEX Phase 2 Clinical Trial of VT-X7 for Periprosthetic Joint Infection

MADRID, Spain and BOSTON, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that its management will give an update on corporate progress at several international events in November.

Read the original post:
ORYZON to Give Updates on Corporate Progress in November

Negma Group has converted 120 convertible bonds in Oxurion resulting in a EUR 300,000 capital increase. This is part of Negma Group’s EUR 30 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eye drug candidate targeting potential market opportunities of over USD 5 billion.

See the article here:
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA

WALTHAM, Mass., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company approved the grant of equity awards to 7 new employees with a grant date of November 1, 2022, as equity inducement awards outside of the company's 2017 Stock Incentive Plan (but under the terms of the 2022 Inducement Stock Incentive Plan) and material to the employees’ acceptance of employment with the company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).

Originally posted here:
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Paging plastics, Dr. Jackson Avery is returning to Grey Sloan Memorial. Jesse Williams will be reprising his role in an upcoming episode of the hit medical drama. Williams will guest star and direct the fifth episode of season 19, When I Get to the Border, airing on November 3.

After twelve seasons of playing the famous plastic surgeon, Dr. Avery, the show announced that Williams would leaveGreys Anatomyin its seventeenth season. The news of the actors departure was revealed in the fourteenth episode of season 17, and his final appearance as a series regular was in the following episode.

In episode fifteen, Jackson moved to Boston to run his familys foundation. Sarah Drew, who embodied one of Williams love interests, and fellow surgeons, Dr. April Kepner, also appeared in the episode as a guest star. Williams and Drew returned to the series again last season, revealing that their characters had reconciled their relationship.

Deadlinereported that Williams will only appear in the upcoming episode in passing. Dr. Avery will catch up with Ellen Pompeos Dr. Meredith Grey when she takes a trip to Boston. Episode five of the new season will be the fourth episode of the ABC drama that Williams has directed.

News of Williams return is not the first development from season 19 regardingGreys Anatomysveteran cast members. Before the seasons premiere, Deadline also reported that Pompeo will scale back her appearances as the shows titular character. In addition, Pompeo will only appear in eight episodes of the new season to have time to pursue other projects.

Fans are thrilled that Dr. Avery will return to the series and are excited to tune in to the next episode of Greys Anatomy. All episodes ofGreys Anatomyare available to stream on Hulu.

Read the rest here:
Jesse Williams Returning to 'Grey's Anatomy' in New Episode - Glitter Magazine